Keep pulling the thread on Federal Reserve.
The U.S. Justice Department initiated a criminal probe into Federal Reserve Chair Jerome Powell, which caused a jolt to financial markets.
At the Consumer Electronics Show, NVIDIA and AMD announced next-generation, rack-scale, two-ton systems designed for building AI infrastructure.
Daniel Newman of Futurum Group predicts that 2026 will be the year of widespread AI monetization.
Google is partnering with Walmart, Target, and Shopify to deploy chatbots powered by its Gemini model to assist consumers.
Dulie Rodrigo of KPMG predicts that future retail interactions will involve AI agents representing consumers communicating directly with AI agents representing retailers.
Ali Furman of PwC predicts an exponential increase in the adoption of GLP-1 drugs in 2026.
The percentage of U.S. households with at least one GLP-1 user increased from 9% in January 2025 to a projected 20% by December 2025.
An oral pill form of a GLP-1 drug from Novo Nordisk has received regulatory approval.
Eli Lilly has an oral GLP-1 drug in its pipeline that is currently undergoing the regulatory approval process.
Consumers using GLP-1 drugs are reallocating their spending towards gym memberships, travel, wellness, active vacations, athleisure, and smaller clothing, while buying fewer accessories.
Early results from retailers indicate a mild holiday shopping season in Q4.
Abercrombie & Fitch shares declined after the company reduced the high end of its financial forecast.